We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Ken Carson is a board-certified practicing hematologist and medical oncologist who currently serves as senior medical director at Flatiron Health, where he focuses on real-world evidence generation. Over the course of his career, Ken’s research has focused on the use of large electronic databases to evaluate health care disparities and oncology drug safety.
Ken also currently practices at Washington University where he specializes in the diagnosis and treatment of patients with hematologic malignancies like lymphomas and leukemia. He joined Washington University School of Medicine’s faculty in 2008 and later served as chief of hematology and oncology at the St. Louis Veterans Affairs Medical Center.
Ken received his medical degree from the University of Southern California, Keck School of Medicine followed by residency training at Duke University, and research and clinical fellowships at Northwestern University. Ken also received a PhD (with an emphasis in health policy and administration) from the University of Illinois School of Public Health.
This speaker's sessions: